Evaluating the real-world benefits and risks of anti-tumor necrosis factor therapies

Audrey Low, Kimme Hyrich

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)4-6
    Number of pages2
    JournalJournal of Rheumatology
    Volume40
    Issue number1
    DOIs
    Publication statusPublished - Jan 2013

    Cite this